Cargando…
Antiplatelet therapy: a double-edged sword in head injury?
Antiplatelet therapy for the treatment of cardiovascular diseases is common in the ageing population. Whether this therapy exacerbates brain injury after head trauma is an important, but unsettled, topic. In this issue of Critical Care, Fabbri and colleagues address the question of whether pre-injur...
Autores principales: | Beynon, Christopher, Sakowitz, Oliver W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672536/ https://www.ncbi.nlm.nih.gov/pubmed/23635332 http://dx.doi.org/10.1186/cc12597 |
Ejemplares similares
-
MAVS is a double-edged sword
por: Huang, Christina, et al.
Publicado: (2023) -
Clinical review: Traumatic brain injury in patients receiving antiplatelet medication
por: Beynon, Christopher, et al.
Publicado: (2012) -
Interactions of Viruses with Dendritic Cells: A Double-edged Sword
por: Bhardwaj, Nina
Publicado: (1997) -
Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword
por: Jia, Guanghong, et al.
Publicado: (2015) -
Autophagy in dental tissues: a double-edged sword
por: Zhuang, H, et al.
Publicado: (2016)